WIF1 and neoplasm: Moreover, WIF-1 expression levels were observed to decrease in PR group and increase in PD group at therapy-Cycle 6 (Figure 6A), differing from previous findings of its anti-tumor effects in CC via the Wnt signaling pathway (55, 56).